FATUZZO, Pasquale Mario
 Distribuzione geografica
Continente #
NA - Nord America 10.720
EU - Europa 4.544
AS - Asia 4.421
SA - Sud America 838
AF - Africa 431
Continente sconosciuto - Info sul continente non disponibili 393
OC - Oceania 6
Totale 21.353
Nazione #
US - Stati Uniti d'America 10.301
SG - Singapore 2.434
RU - Federazione Russa 1.184
CN - Cina 1.132
IT - Italia 875
IE - Irlanda 801
UA - Ucraina 788
BR - Brasile 665
CA - Canada 345
VN - Vietnam 342
FR - Francia 272
CI - Costa d'Avorio 210
DE - Germania 190
SE - Svezia 130
NG - Nigeria 104
IN - India 102
GB - Regno Unito 100
BD - Bangladesh 98
KR - Corea 83
AR - Argentina 79
MX - Messico 31
ZA - Sudafrica 31
NL - Olanda 30
SN - Senegal 29
UZ - Uzbekistan 28
IQ - Iraq 27
PL - Polonia 27
CH - Svizzera 25
EC - Ecuador 25
AT - Austria 22
TR - Turchia 22
CO - Colombia 21
ID - Indonesia 19
ES - Italia 17
FI - Finlandia 17
GR - Grecia 17
HK - Hong Kong 17
JP - Giappone 17
KE - Kenya 17
MA - Marocco 15
VE - Venezuela 15
PK - Pakistan 13
MY - Malesia 11
PY - Paraguay 11
CL - Cile 10
SA - Arabia Saudita 10
AL - Albania 8
LB - Libano 8
IR - Iran 7
JO - Giordania 7
TT - Trinidad e Tobago 7
DZ - Algeria 6
LT - Lituania 6
NP - Nepal 6
PH - Filippine 6
PT - Portogallo 6
AU - Australia 5
BG - Bulgaria 5
ET - Etiopia 5
JM - Giamaica 5
KZ - Kazakistan 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EG - Egitto 4
EU - Europa 4
GT - Guatemala 4
HU - Ungheria 4
OM - Oman 4
AO - Angola 3
BB - Barbados 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
NI - Nicaragua 3
PR - Porto Rico 3
RS - Serbia 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
KN - Saint Kitts e Nevis 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
SM - San Marino 2
VG - Isole Vergini Britanniche 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
GD - Grenada 1
GE - Georgia 1
Totale 20.951
Città #
Dallas 1.456
Singapore 1.358
Houston 1.271
Santa Clara 1.011
Jacksonville 864
Dublin 800
Chandler 706
San Jose 661
Moscow 433
Ashburn 389
Boardman 345
Chicago 307
Nanjing 266
Andover 233
Lawrence 232
Cambridge 230
Toronto 228
Abidjan 210
Lauterbourg 207
Council Bluffs 197
Beijing 145
Los Angeles 139
Des Moines 133
Ho Chi Minh City 127
Catania 122
San Mateo 117
Wilmington 103
Grafing 93
New York 89
Seoul 83
Nanchang 81
Shenyang 80
Saint Petersburg 75
Hanoi 70
Buffalo 64
Civitanova Marche 58
Hebei 57
Rome 54
Hefei 53
Ottawa 53
São Paulo 52
Abuja 51
Jiaxing 50
Lagos 48
Milan 47
Changsha 44
Tianjin 38
Bremen 32
Orem 30
Dakar 29
Kochi 29
Rio de Janeiro 29
Seattle 28
Atlanta 26
Brooklyn 26
Montreal 22
Pune 20
The Dalles 20
Columbus 18
Dong Ket 18
Chennai 17
Denver 17
Tokyo 17
Amsterdam 16
Da Nang 16
Hangzhou 16
Johannesburg 16
Norwalk 16
Charlotte 15
Nuremberg 15
San Francisco 15
Boston 14
Florence 14
Redondo Beach 14
Stockholm 14
Warsaw 14
Haiphong 13
Helsinki 13
London 13
Curitiba 12
Guarulhos 12
Guayaquil 12
Hong Kong 12
Mumbai 12
Padova 12
Poplar 12
Dhaka 11
Kunming 11
Ningbo 11
Noto 11
Palermo 11
Phoenix 11
Zhengzhou 11
Baghdad 10
Belo Horizonte 10
Buenos Aires 10
Guangzhou 10
Liberty Lake 10
Nairobi 10
Porto Alegre 10
Totale 14.373
Nome #
Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients 946
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis 340
Molecular and clinical studies in five index cases with novel mutations in the GLA gene 307
LA DIMETILARGININA ASIMMETRICA (ADMA) INTERAGISCE CON L’FGF-23 NEL PREDIRE LA PROGRESSIONE DEL DANNO RENALE NEI PAZIENTI CON STADIO 2-5 DI MALATTIA RENALE CRONICA 228
Microplastics exposure in dialysis patients: preliminary results of a case-control study 226
A systematic review of arterial stiffness, wave reflection and air pollution 197
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 194
Aferesi terapeutica in paziente con crioglobulinemia (contributo clinico) 171
ADPKD: valutazione di patologia cistica epididimaria e quadro spermatico 169
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease 163
Arteriovenous fistula and pre-surgery mapping: Potential role of physical exercise on endothelial function 163
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 157
Aberrant right subclavian artery laceration due to internal jugular vein catheterization treated by stent -graft implantation 150
Il Fosforo: nuovo fattore di rischio cardiovascolare? [Phosphorus: A new cardiovascular risk factor?] 149
Alterazioni carotidee nell’insufficienza renale cronica 149
Asymmetric dimethylarginine (ADMA),left ventricular hypertrophy and systolic dysfunction in hemodialysis patients 148
Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: A prospective cohort study in outpatient renal clinics 146
ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVELS IN CHRONIC KIDNEY DISEASE: A SALTY QUESTION? 144
Pazienti con insufficienza renale cronica: risultati dallo studio Nefrodata [Characteristics of patients with chronic kidney disease referred to a nephrology outpatient clinic: results of Nefrodata study] 138
Alterazioni carotidee in corso di insufficienza renale cronica 137
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention 135
Atrial Natriuretic Peptide (ANP), Brain Natriuretic Peptide (BNP) and Left Atrial Volume: a longitudinal study in End Stage Renal Disease (ESRD) patients. JASN 2008;19:719A. 134
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 134
Eventi avversi e trigger C12: Stroke in ospedale 133
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients 131
Wegener: nostro contributo clinico 131
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 129
ADPKD:rilevanza del rischio cardio-vascolare in un gruppo di pazienti non complianti alla terapia antipertensiva. 125
PLASMA CONCENTRATION OF ASYMMETRICAL DYMETHYLARGININE AND MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE: “A PROSPECTIVE STUDY” . 124
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 124
Arterial pressure determinant of LVH in uremic patients. 121
Aspergillosis in Hemodialysis Patient 119
An Unusual Association: Fahr's Syndrome And Chronic Kidney Disease 119
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study 119
Ultrasuoni versus rx nella dislocazione del catetere peritoneale: mito o raltà? 118
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients. 116
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 115
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease 114
Sepsi e Polimixina (contributo) 113
La PET con C-Metionina: un approccio propositivo nel trattamento dell'iperparatiroidismo 112
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease 111
raised Asymmetric Dimethyl Arginine is Associated With High Plasma Norepinephrine in Patients with ESRD 110
Ascessi Renali:patologia emergente in soggetti di giovane età 110
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism 109
LIVELLI DI PTX 3 IN PAZIENTI CON INSUFFICIENZA RENALE CRONICA (IRC) 108
Valutazione clinica dell'efficacia terapeutica dell'acebutololo nell'ipertensione arteriosa. 108
Digoxin and Hypermagnesuria 107
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 105
Rapporti dei peptidi natriuretici con la struttura e la funzione cardiaca nell'insufficienza renale cronica terminale: analogie e differenze tra ANP, BNP, CNP e DNP. 105
Vascular dysfunction in Cardiorenal Syndrome type 4 105
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients 103
IL2 and its receptors in elderly subjects on hemodialysis 103
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure 103
LIVELLI PLASMATICI DELLE PENTRAXINE “SHORT” (PROTEINA C REATTIVA) E DELLE PENTRAXINE “LONG” (PTX3) NELLA INSUFFICIENZA RENALE E NEL TRATTAMENTO EMODIALITICO 100
Metformin and kidney 100
Letter regarding the article "The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study". 99
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 99
DIAGNOSTIC POTENZIAL OF CARDIAC NATRIURETIC PEPTIDES IN DIALYSIS PATIENTS 99
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery disease 98
Utilità dell’sCD14-ST per la diagnosi di sepsi nel paziente con insufficienza renale [Usefulness of sCD14-ST in the diagnosis of sepsis in patient with renal failure] 97
Peritonite da Candida e sepsi da Acinetobacter baumannii in dialisi peritoneale: una associazione con la prognosi non è sempre sfavorevole 96
Magnesium, calcium and potassium: "no one was born alone" 96
Il rituximab nella terapia delle glomerulonefriti primitive e secondarie [Use of rituximab in primary and secondary glomerulonephritis] 96
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? 95
Complicanze tardive legate al posizionamento del catetere venoso centrale: le complicanze meccaniche 95
L’IMMUNITÀ INNATA E LA PROGRESSIONE DELLA MALATTIA RENALE CRONICA 95
Il paradosso nefrologico 95
Gli inibitori del trasportatore Sodio-Glucosio di tipo 2 (SGLT2) nell’insufficienza renale cronica [Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors in CKD] 95
L’interleuchina-6 è implicata in maniera causale nell’alto rischio cardiovascolare della malattia renale cronica: uno studio di randomizzazione mendeliana 94
Il fumo, la pressione arteriosa e l'albuminemia sono fattori predittivi indipendenti dal danno vascolare negli uremici in dialisi 93
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients 92
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients 92
Heart rate, age and the risk progression to kidney failure in patients with CKD 91
CHLAMYDIA PNEUMONIAE, OVERALL AND CARDIOVASCULAR MORTALITY IN END STAGE RENAL DISEASE 91
Prevalenza degli anticorpi sierici anti-virus dell'epatite C in pazienti emodializzati. 91
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the excite trial 91
Review: UPDATE sul metabolismo del magnesio 91
Ruolo della Dialisi Peritoneale nel trattamento dei Pazienti con Scompenso Cardiaco Congestizio 89
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 89
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 89
Comparative study of biochemical markers of bone formation in relation to different dialysis age 88
Diagnosis of renovascular disease by extra-end intrarenal doppler parameters 88
ITALIAN AUDIT ON THERAPY OF HYPERTENSION IN CHRONIC KIDNEY DISEASE: TABLE-CKD STUDY 88
Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease 88
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 88
Comportamento delle transaminasi sieriche in corso di infezione da HBV e HCV in pazienti emodializzati 86
Psichiatria di Liaison:Contributo sperimentale allo studio della Qualità di dei DializzatiVita 86
Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients 86
Pyelonephritis: Epidemiology, pathogenesis and management 85
Manuale italiano di cateterismo venoso centrale in nefrologia : Dalla teoria alla pratica clinica quotidiana 85
High Variability of Fabry Disease Manifestations in an Extended Italian Family 85
Renal diseases related to MYH9 disorders 85
Renal transplantation parenchymal complications: what Doppler ultrasound can and cannot do 84
Circulating E-selectin as a risk marker in patients with end-stage renal disease 84
GESTIONE CLINICA DELL’IRC: DATI CAMPANO-SICILIANI DELLO STUDIO TABLE 84
THE ENDOGENOUS INHIBITOR OFF e NOs ASIMMETRIC DIMETHYLARGININE (ADMA) IS HIGHER IN CAPD THAN IN HD PATIENTS 84
LA ELASTICITA’ ARTERIOSA, VALUTATA MEDIANTE PULSE WALVE VELOCITY E A. INDEX E LO SPESSORE MEDIO INTIMALE, E’ PRECOCEMENTE ALTERATA IN PAZIENTI CON IRC NON DIABETICI 84
Valutazione del Filtrato Glomerulare prima edopo Regime proteico Controllato 84
The effect of tumor necrosis factor antagonists on functional aortic stiffening 84
Propyonil-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease (PAD) and end stage renal disease (ESRD) 84
Totale 12.533
Categoria #
all - tutte 73.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.447 0 250 4 22 262 12 245 63 166 1 41 381
2022/20232.278 249 69 35 180 215 454 5 376 590 15 73 17
2023/2024942 62 202 61 60 34 104 18 51 4 37 205 104
2024/20253.756 34 623 240 159 815 397 44 153 330 416 227 318
2025/20267.585 415 205 1.531 495 1.284 1.280 1.105 168 373 353 176 200
2026/2027533 235 298 0 0 0 0 0 0 0 0 0 0
Totale 21.353